Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 41 - 60
of 247
Sorted by Relevance
|
Sort by Date
30 May 2017, 10:10 am
Merrell Dow Pharmaceuticals Inc. [read post]
28 Jul 2011, 11:19 am
He didn't file suit, however, until June 2009.Dead to rights under the Texas two-year statute of limitations, plaintiff tried to argue that his claim didn't "accrue" until there was scientific evidence sufficient to satisfy Texas' version of Daubert, which was imposed in Merrell Dow Pharmaceuticals, Inc. v. [read post]
5 Jan 2019, 12:15 pm
Merrell Dow Pharmaceuticals, Inc., U.S. [read post]
11 Oct 2018, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), an increasing number of expert witnesses have been challenged by way of a Daubert motion. [read post]
18 Dec 2009, 11:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
31 Oct 2016, 10:40 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
31 Oct 2016, 10:40 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
7 Mar 2016, 8:51 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), that is relevant in determining the admissibility of such testimony. [read post]
9 Mar 2009, 7:31 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). [read post]
29 Jun 2020, 12:41 pm
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), and the testimony is helpful to the trier of fact to understand the evidence through specialized, scientific, or technical expertise. [read post]
13 Mar 2018, 6:00 am
Fleetwood Homes of Pennsylvania, Inc., 878 A.2d 509 (Me. 2005) although more Daubert than Frye. [read post]
18 Jun 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which focuses on an analysis of enumerated factors when determining expert admissibility. [read post]
21 Nov 2010, 12:10 pm
Merrell Dow Pharmaceuticals, Inc., 959 F.2d 1349 (6th Cir.) [read post]
13 Feb 2018, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
2 Jul 2019, 8:40 am
Merrell Dow Pharmaceuticals, Inc. [read post]
2 Jul 2019, 8:40 am
Merrell Dow Pharmaceuticals, Inc. [read post]
11 Mar 2014, 10:22 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
4 Aug 2010, 7:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) established the test federal (and many state) judges currently use to determine the admissibility of expert testimony in trials and other proceedings. [read post]
22 Mar 2010, 4:13 am
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir.), cert denied, 516 U.S. 869 (1995); see also In re W.R. [read post]
19 May 2014, 5:22 am
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786 [1993]); that even if the District Court determines that Daubert does not apply to Social Security hearings, the ALJ’s decision violates the agency’s policy of refraining from reliance on vocational expert witness testimony which is unreliable; and that the ALJ’s acceptance of expert testimony when the expert is unable to cite any source for his opinion about the numbers of… [read post]
